PCSK9 and atherosclerosis: Thus, the present study was aimed to evaluate the long-term therapeutic effect of nanoliposome-displayed PCSK9 as an alternative peptide-based vaccine for the treatment of hypercholesterolemia and atherosclerosis in C57BL/6 mice.